Hodgkin's disease in the bone marrow

Authors

  • Raymond B. Weiss MD,

    Corresponding author
    1. Section of Medical Oncology, Department of Medicine, and the Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, MN 55455
    • Department of Medicine, West Virginia University Hospital, Morgantown, WV 26506
    Search for more papers by this author
  • Richard D. Brunning MD,

    1. Section of Medical Oncology, Department of Medicine, and the Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, MN 55455
    Search for more papers by this author
  • B. J. Kennedy MD

    1. Section of Medical Oncology, Department of Medicine, and the Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, MN 55455
    Search for more papers by this author

Abstract

Tumor involvement of the bone marrow in patients with Hodgkin's disease may be suspected in the presence of other manifestations of advanced disease such as fever, lymphopenia, hypoalbuminemia, mixed cellular histologic type, or Stage III or IV disease by other clinical parameters. It occurs more frequently in the older age groups. When anemia, leucopenia, and/or thrombocytopenia are present and are unrelated to recent bone marrow suppressant chemotherapy, marrow involvement is likely to be present. Bone marrow examination, done by multiple trephine biopsies, provides an adequate sampling of tissue and results in a high incidence of detection of involvement by Hodgkin's disease. This manifestation of Hodgkin's disease is associated with a relatively short survival. Aggressive combination chemotherapy is necessary to produce a significant remission.

Ancillary